Redington Board to Consider Q2 and Half-Yearly Results on November 5, 2025
The Board of Directors of Redington is scheduled to meet on November 5, 2025, to review and approve the unaudited financial results for the…
Vedanta Unaudited Consolidated Results for Quarter and Half Year Ended September 30, 2025
Vedanta Limited has announced its unaudited consolidated financial results for the second quarter and half year ended September 30, 2025. The…
Kalpataru Projects Reports Unaudited Financial Results for Q2 FY26
Kalpataru Projects International Limited announced its unaudited consolidated financial results for the quarter and half-year ended September…
Shriram Finance Q2 FY26 Profit Rises 11.39%, Interim Dividend Declared
Shriram Finance (SFL) reported an 11.39% increase in profit after tax to Rs. 2,307.18 crores for Q2 FY26. The board declared an interim…
GAIL (India) Limited Integrated Financial Results for Quarter and Half-Year Ended September 30, 2025
GAIL (India) Limited has announced its integrated financial results for the quarter and half-year ended September 30, 2025. The results,…
Maruti Suzuki India Q2 FY26 Results – Profit Surges Amid Strong Performance
Maruti Suzuki India reported strong Q2 FY26 results, with profit before tax reaching ₹43,393 million and total comprehensive income at ₹36,095…
Dr. Lal PathLabs Board Approves Bonus Issue, Dividend, and Stock Option Plan
Dr. Lal PathLabs’ board has approved a bonus issue of 1:1, a ₹7 per share interim dividend, and a new employee stock option plan (ESOP).…
Sammaan Capital Unaudited Financial Results for Quarter Ended September 30, 2025
Sammaan Capital Limited (formerly Indiabulls Housing Finance Limited) has announced its unaudited consolidated financial results for the…
Aptus Value Housing Finance Declares Interim Dividend & Approves Promoter Reclassification
Aptus Value Housing Finance India has declared an interim dividend of ₹2 per equity share (100% of face value) for the financial year 2025-26,…
Jubilant Pharmova Reports Q2 FY26 Results; API Business Sale Completed
Jubilant Pharmova reported its Q2 FY26 results, highlighting a revenue of ₹19,664 million. The company also completed the sale of its Active…